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Patients with Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI) may present
anosognosia for their cognitive deficits. Three different methods have been usually used
to measure anosognosia in patients with AD and MCI, but no studies have established
if they share similar neuroanatomical correlates. The purpose of this study was to
investigate if anosognosia scores obtained with the three most commonly used methods
to assess anosognosia relate to focal atrophy in AD and MCI patients, in order to
improve understanding of the neural basis of anosognosia in dementia. Anosognosia was
evaluated in 27 patients (15 MCI and 12 AD) through clinical rating (Clinical Insight Rating
Scale, CIRS), patient-informant discrepancy (Anosognosia Questionnaire Dementia,
AQ-D), and performance discrepancy on different cognitive domains (self-appraisal
discrepancies, SADs). Voxel-based morphometry correlational analyses were performed
on magnetic resonance imaging (MRI) data with each anosognosia score. Increasing
anosognosia on any anosognosia measurement (CIRS, AQ-D, SADs) was associated
with increasing gray matter atrophy in the medial temporal lobe including the right
hippocampus. Our results support a unitary mechanism of anosognosia in AD and MCI,
in which medial temporal lobes play a key role, irrespectively of the assessment method
used. This is in accordance with models suggesting that anosognosia in AD is primarily
caused by a decline in mnemonic processes.
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INTRODUCTION
Awareness of our own performance is a critical component of normal cognition that gives us the
ability to recognize our limits and plan our behavior accordingly. But patients with Alzheimer’s
Disease (AD) and its pre-dementia counterpart indicated as Mild Cognitive Impairment (MCI)
are frequently unaware of their cognitive and behavioral deficits (Morris and Mograbi, 2013;
Sunderaraman and Cosentino, 2017). The inability to recognize cognitive, behavioral, or functional
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impairment occurring as a consequence of a dementing illness is
indicated as anosognosia, loss of insight, or unawareness of disease
(Babinski, 1914). Anosognosia in patients with MCI and AD has
significant clinical implications for their care, in that reduces
compliance to treatment, threatens patient’s safety, and increases
caregiver burden (Starkstein et al., 2007). Many previous studies
exploring aspects of anosognosia in people with MCI and
AD have led to heterogeneous and sometimes inconsistent
findings concerning the association of anosognosia with
neuropsychological and psychiatric characteristics (Kaszniak and
Edmons, 2010; Starkstein et al., 2010; De Carolis et al., 2015),
severity of disease (Sunderaraman and Cosentino, 2017), and
underlying neuroanatomical correlates (Zamboni and Wilcock,
2011; Cosentino et al., 2015). The cause of this variability may in
part reflect different approaches used to study insight, that can
be broadly classified in clinical approaches adopting the clinical
concept of anosognosia or approaches from cognitive psychology
adopting the concept of metacognition (Sunderaraman and
Cosentino, 2017). These different approaches have in turn used
different methods to measure anosognosia (or metacognition)
(Clare et al., 2011). A first method usually indicated as “clinician
rating” is based on the judgment of the clinician who rates the
patient’s level of awareness along an ordinal scale, following
structured or unstructured interviews with the patients and the
caregiver. The second method usually indicated as “patient-
informant discrepancy” is based on the calculation of discrepancy
scores between parallel questionnaire for the patient and for
their caregiver, in which they both describe the patient’s
potential symptoms (Hannesdottir and Morris, 2007). These
two approaches are commonly used in clinical settings and
measure anosognosia in patients with dementia in an oﬄine
way (Sunderaraman and Cosentino, 2017). The third method
usually indicated as “performance discrepancy” is based on the
comparison between the patient’s actual performance on a certain
neuropsychological test and their estimation of how well they
think they performed immediately prior to or following the
execution of the specific test. Variations of this method have been
traditionally used to assess meta-cognitive abilities in healthy
subjects in cognitive psychology studies, but have recently been
increasingly used to measure online and immediate insight in
patients with dementia (Martyr et al., 2014).
However, only a few studies have directly compared the three
methods in the same sample of patients (Hannesdottir and
Morris, 2007; Leicht et al., 2010; Clare et al., 2011). Hannesdottir
and Morris used clinician rating, patient-informant discrepancy,
and performance discrepancy to assess anosognosia in 92 AD
patients. They found that only clinician rating and patient-
informant discrepancy were reciprocally correlated, whereas
performance discrepancy was related to measures of memory
and executive functioning (Hannesdottir and Morris, 2007). The
same authors had previously suggested a neuropsychological
model of anosognosia that distinguishes between primary
anosognosia, which directly affects a long-term system specific
for self-awareness, and secondary anosognosia, which instead is
secondary to memory or executive dysfunction that affects the
immediate ability to judge cognitive performance (Agnew and
Morris, 1998; Morris and Hannesdottir, 2004). They concluded
that clinician rating and patient-informant discrepancy inform
about longer term awareness (i.e., primary anosognosia),
whereas performance discrepancy reflects the impairment of the
online ability to judge cognitive performance (i.e., secondary
anosognosia) (Hannesdottir and Morris, 2007). Another study
conducted in 32 patients with AD gave similar results, suggesting
that different methods of measurement may capture different
facets of anosognosia (Leicht et al., 2010).
Imaging studies looking at the neuroanatomical correlates of
anosognosia have typically adopted only one among the three
above mentioned methods and correlated it with measures of
brain variability, such as metabolism or gray matter atrophy.
However, in a review on the neuroanatomical correlates of
anosognosia it was observed that studies using performance
discrepancy showed associations between anosognosia and
atrophy or hypo-metabolism mainly in frontal regions, whereas
studies using patient-informant discrepancy more frequently
showed involvement of temporo-parietal regions, although the
results may have been biased by a tendency to only focus
on frontal regions in some of the older studies (Zamboni
and Wilcock, 2011). To our knowledge, no imaging studies
have simultaneously studied the neuroanatomical correlates of
the three different methods most commonly used to assess
anosognosia.
Here we investigated the brain correlates of anosognosia
assessed with clinical rating, patient-informant discrepancy,
and performance discrepancy in a sample of AD and MCI
patients. We reasoned that if different measures of anosognosia
would have different neuroanatomical correlates it would
imply that they capture different aspects and possibly different
mechanisms of anosognosia. Alternatively, if different measures
of anosognosia would show overlapping neuroanatomical
correlates, it would support that anosognosia in MCI and
AD can be studied either through the cognitive construct of
meta-cognition or the clinical construct of anosognosia. More
precisely, we hypothesized that such unitary model would rely on
medial temporal structures in line with the most recent revision
of the theoretical model of anosognosia, which suggests that
anosognosia in AD is mainly caused by a decline in specific
mnemonic processes ultimately leading to the loss of personal
knowledge (Morris and Mograbi, 2013).
MATERIALS AND METHODS
Participants
Twenty-seven elderly participants took part in the study. Fifteen
had a diagnosis of amnestic MCI (a-MCI) and 12 had a
diagnosis of AD. Exclusion criteria were severe head trauma or
prior neurological disorders, major psychiatric disorder, possible
vascular or mixed origin of the cognitive dysfunction, and
evidence of cerebral lesions on MRI scan, including evidence
of small vessel disease (infarcts, lacunes, micro-bleeds, or white
matter hyper-intensities). Participant were recruited from the
Memory Clinic of the Neurological Department of the Nuovo
Ospedale Civile S. Agostino-Estense (Baggiovara, Modena, Italy).
They were asked to participate with an informant who knew
them well enough to give information about their activities of
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daily living and cognitive performance. Clinical diagnoses of
amnestic MCI and ADwere made according to published criteria
(McKhann et al., 1984; Petersen et al., 1999; Winblad et al., 2004).
Participants underwent medical and neurological examination.
neuropsychological assessment, and MRI scan. Participant’s
study partners were interviewed to gain additional information
about subject’s cognitive, functional, and behavioral status. The
study was conducted under ethical approval of the Local Ethics
Committee (Comitato Etico Provinciale di Modena, code 252.09,
approved on 21/04/10) and all subjects gave written informed
consent before participating. The degree of cognitive impairment
was assessed by the Mini-Mental State Examination (MMSE,
Folstein et al., 1975). Standard neuropsychological assessment
was performed, including measure of verbal fluency, visuospatial
and verbal memory, executive functions, and attention. The
Clinical Dementia Rating Scale (CDR, Morris, 1993) was
administered to the caregiver to measure dementia severity (AD:
rated as 1; a-MCI: rated as 0.5). The distress of caregiver was ruled
out through the Caregiver Burden Inventory (CBI, Novak and
Guest, 1989).
Assessment of Anosognosia
We used 3 methods to assess anosognosia:
1. Clinician ratings on theClinical Insight Rating Scale, CIRS (Ott
et al., 1996; Zanetti et al., 1999). The CIRS define 4 domains
of patient’s awareness: (a) the reason for the visit; (b) the
cognitive deficits; (c) functional deficits; (d) perception of the
progression of deficits. Based on separate interview with the
patient and the caregiver, the items are rated by the examiner
as 0 (full insight), or 1 (partial insight), or 2 (non-insight), and
summed to obtain a total score between 0 and 8. Patients with
a total score ≥2 were considered anosognosic;
2. Patient-informant discrepancy score evaluated by
Anosognosia Questionnaire Dementia (AQ-D, Migliorelli
et al., 1995). The questionnaire consists of 30 questions
divided in 2 sections, the cognitive and the behavioral
aspects. The cognitive part assesses cognitive function and
performance, in basic and instrumental activities of daily
living. The behavioral part assesses changes in interests and
mood. The same questions were administered to patients
(Form A) and to caregivers (Form B) who were blinded
to the patient’s answers. The total AQ-D score is given by
the difference between Form B and Form A. Higher score
indicated a reduced awareness of deficits, meaning that
caregivers rated the patients more impaired that did the
patients;
3. Performance discrepancy was assessed by asking patients
to retrospectively rate their own performance on different
neuropsychological tests (Leicht et al., 2010; Rosen et al., 2010)
then calculating a Self-appraisal Discrepancy (SAD) score for
each test. We focused on tests of memory and executive
function as these cognitive domains have been those most
frequently associated with anosognosia (Lopez et al., 1994;
Kashiwa et al., 2005; Hannesdottir and Morris, 2007). More
precisely we included Babcock Story Recall (Carlesimo et al.,
2002) and Rey Auditory-Verbal Learning Test-Delayed Recall
(Carlesimo et al., 1996) for verbal memory, Rey-Osterrieth
Complex Figure-Recall (Bertolani et al., 1993) for visuo-spatial
memory, the Stroop Test (Caffarra et al., 2002), and the
Frontal Assessment Battery (FAB, Appollonio et al., 2005) for
executive function. Patients were asked to rate their perception
of performance on these tests by assigning themselves a score
on a 5-point scale ranging from 0 (very poor) to 4 (very good).
Raw scores on each of the cognitive tasks were converted into
equivalent score using published norms. The performance
score was subtracted from the self-rating score, resulting
in a Self-appraisal Discrepancy (SAD) score between −4
(underestimation of performance) and +4 (overestimation of
performance), with zero representing perfect accuracy.
Statistical Analyses
Analyses of behavioral and neuropsychological data were
performed with SPSS version 24.0. Comparisons between
MCI and AD groups were performed with Mann-Whitney or
independent t-test, as appropriate, for continuous variables,
and chi-square tests for dichotomous variables, using a level of
statistical significance of p < 0.006 to control for the number
of comparisons (8, including MMSE and all the measures of
anosognosia). Correlations among measures of anosognosia and
between these and neuropsychological tests were also performed,
using a level of statistical significance of p < 0.003 to control
for the number of correlations (14). Pearson’s and Spearman’s
correlation test were used according to the linearity of the
relationship between variables.
Images Acquisition and Analysis
Scanning was performed at Nuovo Ospedale Civile S.Agostino,
Estense, Baggiovara, Modena using a 3-T Philips Intera MRI
scanner equipped with a 12-channel head coil. The images
acquired were high-resolution T1-weighted 3D MP-RAGE
structural images (repetition time 9,900ms; echo time 4.6ms;
field of view 256× 256mm; voxel dimension 1 mm3). Structural
data were analyzed with FSL-VBM, a voxel-based morphometry
style analysis carried out with FSL tools (http://www.fmrib.
ox.ac.uk) (Smith et al., 2004), to detect gray matter (GM)
differences. First, structural images were brain-extracted and
gray matter segmented before being registered to the MNI
152 standard space using non-linear registration (Andersson
et al., 2007). The resulting images were averaged to create
a study-specific template, to which the native gray matter
segmented images were then non-linearly re-registered. The
method also introduces a compensation (or “modulation”) for
the contraction/enlargement due to the non-linear component
of the transformation: each voxel of each registered gray matter
image was divided by the Jacobian of the warp field. The
modulated, registered gray matter images were then smoothed
with an isotropic Gaussian kernel with a sigma of 3mm. Finally,
voxelwise General Linear Modeling (GLM) was applied using
permutation-based non-parametric testing (5,000 permutations).
We performed correlation analyses across the whole cohort of
subjects to examine the relationship between GM volume and
anosognosia assessed by CIRS, AQ-D and SAD with separate
independent GLM models. In all these GLM models, a measure
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of disease severity (MMSE scores) and age were also mean-
centered and entered as covariates of no interest to control
for their potential effects. One-tailed t-tests were performed,
assuming that higher AQ-D, CIRS or SAD scores (indicating
higher anosognosia) would be associated with decreased gray
matter density (or increased focal atrophy). Results from the
different correlational analyses were thresholded, binarised and
overlapped to obtain a density overlap showing common results
across different measures of anosognosia. To definitively rule out
an effect of severity of group on the results, we also conducted
separate correlation analyses in the AD and MCI groups with the
AQ-D.
Results were first explored at the uncorrected voxel-level using
a threshold of p < 0.001, then also after applying correction
for multiple comparisons at the p < 0.05 level (Threshold-Free
Cluster Enhancement, TFCE).
RESULTS
Behavioral Results
There were no significant differences in age, years of education,
reported duration of cognitive complain, and gender between
the AD and MCI groups (Table 1). As expected, global cognitive
decline measured with MMSE was higher in the AD relative
to the MCI group (p = 0.004). Patients with AD had higher
scores in AQ-D and CIRS relative to MCI, but the difference
did not reach a statistical significance after correction for
multiple comparisons. All AD patients had mean positive
discrepancy score in SAD, indicating that they overestimated
their performance.
Correlation analysis between measures of anosognosia
showed significant positive correlations between AQ-D and CIRS
(Sperman’s Rho, rs = 0.61, p = 0.001, Table 2) and between
AQ-D and FAB-SAD (Sperman’s Rho, rs = 0.59, p = 0.002,
Table 2). There was a negative correlation between SAD-Stroop
and MMSE (Sperman’s Rho, rs = −0.60, p = 0.001), whereas all
other measures of anosognosia did not correlate with severity of
disease. AQ-D negatively correlated with actual performance on
the FAB (Sperman’s Rho, rs = −0.75, p < 0.001), suggesting a
relation with executive dysfunction. AQ-D and CIRS showed no
other significant correlations with neuropsychological tests. Self-
appraisal discrepancy (SAD) scores all significantly negatively
correlated with actual performances on their respective tests,
indicating that the higher the SAD, the poorer the performance
in the cognitive test (Table 2).
Imaging Results
Correlation analysis between patient-informant discrepancy
(AQ-D) and gray matter volume across all subjects showed that
higher AQ-D scores (indicating more severe anosognosia) were
associated with greater atrophy in the right medial-temporal
lobe, in particular the hippocampus (p < 0.05, corrected,
age and MMSE entered as covariates, Figure 1, Table 3).
Correlation analysis between clinical rating (CIRS) and gray
matter volume across all subjects gave similar but less significant
results, demonstrating that higher CIRS scores (indicating more
severe anosognosia) are specifically associated with greater gray
TABLE 1 | Demographic and neuropsychological characteristics of participants.
Whole group
(n = 27)
MCI
(n = 15)
AD
(n = 12)
Groups
comparison
Gender F:M 15:12 9:6 6:6 p = 0.6
Age (years) 75.89 (6.22) 76.73
(5.3)
74.77
(7.2)
p = 0.46
Education (years) 5.9 (3.4) 6.6 (3.9) 5.1 (2.6) p = 0.24
Reported duration of
cognitive complain (years)
3.55 (1.9) 3.86
(2.41)
3.16
(1.19)
p = 0.71
MMSE 25.59 (3.2) 27.3
(0.4)
23.4
(1.0)
p = 0.004
AQ-D 2.1 (12.3) −3.0
(9.3)
7.7
(13.1)
p = 0.03
CIRS 1.4 (1.7) 0.8
(1.18)
2.2
(2.13)
p = 0.04
SAD-Babcock Story Recall −0.03 (1.8) −0.60
(2.2)
0.66
(0.77)
p = 0.08
SAD-Rey Auditory-Verbal
Learning Test-Delayed
Recall
0.22 (1.28) −0.2
(1.9)
0.8
(1.02)
p = 0.02
SAD-Rey-Osterrieth
Complex Figure-Recall
−0.26 (1.63) −0.6
(1.9)
0.16
(1.02)
p = 0.21
SAD-Frontal Assessment
Battery
0.88 (1.6) 0.6 (1.6) 1.25
(1.48)
p = 0.30
SAD-Stroop Test 1.11 (1.69) −0.2
(1.38)
0.58
(1.97)
p = 0.20
Reported values are means with standard deviation values in parenthesis. MMSE, Mini-
Mental-State Examination. AQ-D, Anosognosia Questionnaire Dementia; CIRS, Clinical
Insight Rating Scale; SAD, Self-Appraisal Discrepancy; F, Female; M, Male. Mann-Whitney
test was used for duration of cognitive complaint and SAD scores (italic). In bold, p <
0.006.
matter atrophy in structures of the right medial temporal lobe
(p < 0.001, uncorrected, age and MMSE entered as covariates).
Correlation analyses between performance discrepancy (SAD
scores) and gray matter density showed for all the tests a
significant correlation between higher SAD scores (indicating
more severe agnosia) and greater atrophy in the right
hippocampus (p < 0.05 corrected for SAD-FAB, p < 0.001,
uncorrected for all the other SAD scores; age and MMSE entered
as covariates; Figure 2, Table 3). In addition to this significant
association with structures of the right medial temporal lobe,
higher SAD scores of verbal memory (RAVLT and Babcock
Story Recall) were also associated with greater atrophy in
the left hippocampus and amygdala bilaterally (p < 0.001,
uncorrected). Higher SAD score of visuospatial memory (Rey-
Osterrieth Complex Figure-Recall) was also associated with
greater atrophy in the precuneus and lateral occipital cortex
(p < 0.001, uncorrected). Higher SAD scores of executive and
attentive functions were also associated with greater atrophy in
the anterior cingulate gyrus, precentral gyrus, and fronto-orbital
cortex (Figure 2, Table 3).
A density map obtained by overlapping the uncorrected
results of the seven different correlational analyses showed that
a small region in the right anterior hippocampus (cluster size:
6 voxels, MNI coordinates: 28, −14, −20) resulted from all
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TABLE 3 | Regions of significant negative correlation between GM density and CIRS, AQ-D, and SAD scores.
Localization Side Cluster size x y z t p
AQD
Hippocampus R 595 28 −18 −20 3.94 0.024 corr
Amygdala 32 −2 −22 3.44
Parahippocampus 36 −14 −24 3.66
Supramarginal gyrus R 98 50 −38 34 5.08 0.024 corr
Precentral gyrus R 78 64 −4 26 4.7 0.030 corr
SAD-FAB
Anterior Cingulate L 581 −4 −12 44 3.5 0.020 corr
Precentral gyrus −24 −8 50 3.9
Postcentral gyrus R 645 16 −34 72 4.3 0.013 corr
Hippocampus R 121 30 −22 −18 4.7 0.049 corr
CIRS
Hippocampus R 116 30 −20 −18 3.4 <0.001 uncorrected
Amygdala R 108 32 0 −20 2.9
Parahippocampus R 355 24 −28 20 2.7
Amygdala L 77 −34 6 −20 2.9
SAD-RAVLT
Superior frontal gyrus R 11 26 62 20 3.5 <0.001 uncorrected
Amygdala R 15 26 −6 18 3.9
Hippocampus R 78 28 −12 −18 4.4
Parahippocampal gyrus R 33 28 −30 18 3.4
Parahipp L 28 −18 −42 4 4
Superior temporal gyrus L 109 −42 −30 4 5.4
SAD-Babcock
Amygdala L 298 −24 −8 −14 3.2 <0.001 uncorrected
Hippocampus L 430 −22 −16 −22 2.9
Hippocampus R 44 26 −16 −18 2.9
SAD-Rey Figure Recall
Hippocampus R 114 30 −14 −16 3.7 <0.001 uncorrected
Lateral occipital cortex. superior divisio R 322 32 −80 28 4.73
Precuneus L 68 −8 −58 32 3.7
SAD-Stroop
Frontal Orbital Cortex L 444 −34 20 −26 4.1 <0.001 uncorrected
Fusiform gyrus L 665 −38 −64 −18 4.5
Parahippocampal gyrus R 94 28 2 −18 3.4
the different measures of anosognosia and that a larger region
extending to the posterior right hippocampus (cluster size: 37
voxels, same center of gravity) resulted from 5 different measures
of anosognosia (Figure 3).
Further correlation analyses with AD-Q scores were
performed separately for the AD and MCI subgroups to rule
out an effect of disease severity. These analyses showed that the
significant correlation between higher AQ-D scores and greater
atrophy in structures of the medial temporal lobe persisted in
both subgroups (p < 0.001, uncorrected, age and MMSE entered
as covariates, Figure 4). In addition, in the AD group, higher
AQ-D scores were correlated also with greater atrophy in the
anterior and middle cingulate gyri, suggesting an involvement of
these regions in anosognosia only when cognitive impairment is
severe enough to reach the clinical diagnosis of dementia.
DISCUSSION
We investigated the neuropsychological and neuroanatomical
correlates of anosognosia in patients with MCI and AD using
a multidimensional approach. We found that the three most
commonly used measurements of anosognosia, namely clinical
rating (measured with CIRS), patient-informant discrepancy
(measured with AQ-D), and performance discrepancy (measured
with SAD scores on test of memory and executive function) are
all independently associated with gray matter atrophy of medial
temporal structures, particularly the right hippocampus.
We first investigated the behavioral correspondences of
the three methods in order to examine their reciprocal
relationships. Consistently with previous studies, we found
high correlation between the two measures of anosognosia
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FIGURE 1 | Results of VBM correlation analyses between GM density and: (i)
CIRS (Top) and (ii) AQ-D (Bottom). Maps of t-values are thresholded at
p < 0.05 corrected for multiple comparisons for AQ-D and at p < 0.001
uncorrected for CIRS for display purposes. Images are shown in radiological
convention. Coordinates are in MNI.
most frequently used in clinical settings that assess global,
enduring and oﬄine awareness, namely clinical rating and
patient-informant discrepancy (Hannesdottir and Morris, 2007;
Leicht et al., 2010; Clare et al., 2011). Among measures of
discrepancy between performance on neuropsychological tests
and patient’s retrospective appraisal (indicated as performance
discrepancy or self-appraisal discrepancy, SAD), which are
usually considered online dynamic measures of anosognosia,
only the one relative to the frontal assessment battery (SAD-
FAB) correlated with patient-informant discrepancy (AQ-D).
However, among all the tests used for calculating SAD scores,
the FAB was the only one that included a battery of different
sub-tests rather than a single test, therefore it is possible that
in this specific case patients may have relied more on an
enduring oﬄine awareness system rather than on the immediate
retrospective appraisal of actual performance when giving their
judgments.
We then independently explored the specific association
of each anosognosia measurement with focal gray matter
atrophy and consistently found a significant involvement of
the right hippocampus. More precisely, the more severe was
the anosognosia score, the higher was the degree of atrophy
in the right hippocampus, irrespectively of the method used
to measure anosognosia. The association between hippocampus
and measures of anosognosia was independent from patient’s
age or severity of cognitive decline, whose effect was accounted
for in the imaging analyses, and remained significant also when
considering MCI and AD patients separately.
The involvement of the hippocampus and other medial
temporal lobe structures as key structures in anosognosia in
patients with MCI and AD is consistent with several previous
studies (for a recent review see Chavoix and Insausti, 2017).
Specifically, the role of the right hippocampus also emerged in a
post-mortem study correlating neuropathology and anosognosia
in patients with AD: senile plaque density of the presubiculum of
the right hippocampus was significantly higher in anosognosic
relative to aware patients (Marshall et al., 2004). A large PET
multicenter imaging study also showed that anosognosia was
related to hypometabolism in right parahippocampal regions,
suggesting a possible specific role of medial temporal lobe
structures as “comparator” between current information and
personal knowledge of cognitive abilities (Salmon et al., 2006).
But the relevance of the present study is that the three
different methods most commonly used to assess anosognosia
showed overlapping neuroanatomical correlates. This supports
a unitary view on the mechanism leading to anosognosia
in MCI and AD, which is in line with the Cognitive
Awareness Model, a theoretical model of anosognosia first
proposed by Agnew and Morris (Agnew and Morris, 1998;
Morris and Hannesdottir, 2004), rather than supporting
multicomponent/multilevel mechanisms of anosognosia. More
precisely, the specific involvement of medial temporal structures
is in line with the most recent revision of such theoretical
model of anosognosia (Mograbi et al., 2009; Morris andMograbi,
2013). This suggests that the pattern of memory impairment in
MCI and AD may be responsible for the loss of components
of autobiographical memory, which are the first steps necessary
for forming a correct personal knowledge. This in turn is
then necessary to update a more global, enduring, and on-
line self-awareness system, whose neural correlates possibly
involve the frontal cortex. In line with this, it is well known
that the hippocampus and the medial temporal lobe have
a role in supporting episodic and semantic components of
autobiographical memory (Gilboa et al., 2005), that these
structures are specifically involved in AD in its early phases
(Tondelli et al., 2012), and that the hippocampus does not
function as a unitary and isolated entity, but is part of several
complex functional networks that variably adapt to disease
(Zamboni et al., 2013b; Voets et al., 2014).
Interestingly, structures of the rightmedial temporal lobe were
the only significantly correlates emerging when using measures
of enduring, oﬄine global awareness (i.e., clinical ratings and
patient-informant discrepancy). Only when the correlates of
patient-informant discrepancy (AQ-D) were studied in the AD
patients only, significant correlations with atrophy also emerged
in the anterior and mid-cingulate cortices. This result may be in
line with previous studies using functional MRI that showed that
patients with AD present loss of activation of medial prefrontal
cortex in tasks requiring self-monitoring and self-awareness
(Amanzio et al., 2011; Zamboni et al., 2013a; Perrotin et al., 2015).
When using measures of performance discrepancy (SAD
scores), other regions of significant association between
anosognosia and gray matter atrophy emerged in addition to
the right hippocampus, which resulted from all the correlations.
More precisely, performance discrepancy on verbal memory
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FIGURE 2 | Regions of significant correlation between GM density and SAD for the different cognitive domains. Maps of t-values are thresholded at p < 0.001
uncorrected, except for SAD-FAB thresholded at p < 0.05, corrected for multiple comparison. Images are shown in radiological convention. Coordinates are in MNI.
FIGURE 3 | Map of overlap between results (uncorrected p) of the correlational analyses on the 7 different measures of anosognosia. In yellow regions in which all the
7 measures of anosognosia correlate with atrophy. In red regions in which at least 2 measures of anosognosia correlate with atrophy.
(SAD-RAVLT and SAD-Babcock Story Recall) was also
associated with atrophy in the left hippocampus and amygdala.
Performance discrepancy on visuo-spatial memory (SAD-
Rey-Osterrieth Complex Figure-Recall) was also associated
with atrophy in the precuneus and lateral occipital cortex.
Performance discrepancy on executive and attentive functions
(SAD-FAB and SAD-Stroop) was also associated with atrophy
in the anterior cingulate, precentral gyrus and fronto-orbital
cortex. This may suggest that the neural correlates of cognitive
domain-specific anosognosia may include brain structures
known to be directly involved in the specific cognitive function.
Previous studies have hypothesized that patients may have
domain-specific anosognosia for memory (Reed et al., 1993) and
for a range of other possible symptoms including depression,
apathy, and anxiety (Vasterling et al., 1995). Our results may
suggest that the on-line dynamic awareness measured with the
performance discrepancy method depends on the specific neural
networks associated with the execution of the task itself. As
postulated by the revision of the Cognitive Awareness Model
(Morris and Mograbi, 2013), monitoring of performance may
work at multiple levels, explaining the existence of domain-
specific anosognosia: initially, at the first of these levels, sensory
inputs providing information about performance are processed
locally, in domain-specific modules, and only later are integrated
centrally in the self-awareness system. Therefore, our findings
from SAD scores may be again in line with this model and
further support the idea that on-line monitoring relies on a
widespread network in which local “spokes” specific for cognitive
domain are interconnected with central “hubs” in the general
awareness system.
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FIGURE 4 | Results of VBM correlation analyses between AQ-D and gray matter density in MCI (in blue) and AD (in orange) groups. Results are displayed at p <
0.001 uncorrected. Images are shown in radiological convention. Coordinates are in MNI.
However, it should be noted that, differently from several
functional imaging studies that directly tested the neurocognitive
mechanisms at the basis of self-awareness and anosognosia
with experimental paradigms (Amanzio et al., 2011; Zamboni
et al., 2013a; Perrotin et al., 2015), the present study simply
tested associations between the most frequently used methods
to measure anosognosia and brain structure, testing whether
they capture the same variability in the degree of brain regional
atrophy in our sample. Thus, our results capture rather basic
and common features of anosognosia, and do deepen into the
processes underpinning impaired awareness of symptoms in AD
and MCI. Any mechanistic interpretation of our results should
therefore be considered speculative.
One limitation of our study is that our sample of patients
is relatively small and heterogeneous, since we included both
AD and MCI patients. Future studies should be more selective
in recruiting patients in order to distinguish potential specific
features of anosognosia in different stages of AD progression,
and possibly include subtler measures of disease severity as
covariate of no interest. Another limitation is that, while we
used validated questionnaires for clinical rating and patient-
informant discrepancy, namely CIRS and AQ-D, there is no
gold standard yet for measuring performance discrepancy
(Ecklund-Johnson and Torres, 2005). As previously pointed
out by other authors, the procedure most frequently used for
performance discrepancy (namely, prediction of the number
of remembered items from a list) is only suited to investigate
self-appraisal discrepancy on memory performance (Leicht
et al., 2010). We aimed instead to explore performance
discrepancy in other cognitive domains beside verbal memory.
Therefore, we followed the procedure suggested in previous
studies (Leicht et al., 2010; Rosen et al., 2010), aware of the
possible limitations such as the fact that SAD scores may
potentially be influenced by motivation or unmeasured cognitive
functions.
The strength of our study is that it combined behavioral and
imaging investigations of anosognosia simultaneously measured
in the same group of patients with the three most frequently
used methods of assessments. The results were strikingly
converging and highlighted the involvement of medial temporal
lobe structures, in particular the right hippocampus, in the
mechanism underlying anosognosia, however measured. These
results have important theoretical implications in that contribute
to an improved understanding of the neuroanatomical basis of
anosognosia in MCI and AD. They also have direct practical
implication as they suggest that anosognosia in MCI and AD
can be reliably studied either through clinical questionnaires or
through meta-cognitive methods.
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